Skip to main content
Top

Current Treatment Options in Oncology

Issue 4/2017

Content (5 Articles)

Lower Gastrointestinal Cancers (AB Benson, Section Editor)

The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment

Louise C. Connell, José Mauricio Mota, Maria Ignez Braghiroli, Paulo M. Hoff

Sarcoma (SH Okuno, Section Editor)

Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease

Douglas J. Harrison, Cindy L. Schwartz

Sarcoma (SH Okuno, Section Editor)

Image-Guided Thermal Ablative Therapies in the Treatment of Sarcoma

Scott M. Thompson, John J. Schmitz, Grant D. Schmit, Matthew R. Callstrom, Anil Nicholas Kurup

Open Access Lung Cancer (HA Wakelee, Section Editor)

A Neuro-oncologist’s Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung Cancer

Tresa McGranahan, Seema Nagpal

Lung Cancer (HA Wakelee, Section Editor)

Optimal Radiation Therapy for Small Cell Lung Cancer

Michael F. Gensheimer, Billy W. Loo Jr.

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine